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INTRODUCTION
Diagnostic and therapeutic use of radioiodine in thyroid
disorders depends on the ability of thyroid tissue to concen-
trate radioiodine, a thyrotropin (TSH)-stimulated process
mediated by cAMP augmentation of iodine trapping, oxida-
tion, and organification. Various methods have been tried to
enhance thyroidal uptake of radioiodine, including a low iodine
diet (1) and diuretics (2) to reduce body content of stable iodine
and lithium to increase the retention of radioiodine in thyroid
cells (3-5). 
Theophylline, a methylxanthine derivative which inhibits
cellular phosphodiesterases and preserves intracellular cAMP,
may potentiate the effect of TSH. Thirty years ago, Ahn and
Rosenberg observed that theophylline increased iodine organ-
ification (6). After this report, there were few studies which
assessed the direct effect of theophylline on the thyroidal ra-
dioiodine uptake in vitro or in vivo and most of these studies
were done before the 1980s. The aim of this study was to
address the hypothesis that theophylline would augment
radioiodine uptake in vivo by normal mouse thyroid tissue
and in vitro rat thyrocytes in cultures. 
MATERIALS AND METHODS
Thyroidal radioiodine uptake in mice
Ten pairs of adult female C57BL/6j mice were studied. In
each pair, one mouse received 2.5 mg theophylline i.p. dis-
solved in 0.5 mL 0.9% sterile saline, whereas its control re-
ceived only saline. Twenty-hours after theophylline, 10  Ci
Na125I (ICN Biochemicals Inc., Cleveland, OH, U.S.A.) in
0.1 mL 0.9% sterile saline were injected through the tail vein
to all mice. Four hours later, the mice were sacrificed, their
sera collected, and thyroid glands dissected and counted in a
gamma counter (Packard Instrument Co., Downers Grove,
IL, U.S.A.). To determine background radioactivity, a piece
of quadriceps muscle was dissected, weighed, counted and
its radioactivity per weight subtracted from that of thyroid
tissue. Radioiodine uptake was expressed as cpm/mg of thy-
roid tissue. All of the animals were maintained in accordance
with the NIH Guidelines for the Care and Use of Laboratory
Animals, and all experimental procedures were approved by
the institutional animal use and care committee for use of
vertebrate animals in research.
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Theophylline Increases the Uptake of Radioiodine by Mouse Thyroid
Diagnostic and therapeutic use of radioiodine in the management of thyroid disor-
ders depends on the ability of thyroid cells to concentrate radioiodine, a process that
is regulated by the intracellular increase in cAMP. We hypothesized that theophylline, a
drug known to increase intracellular cAMP via inhibition of phosphodiesterase, could
increase thyroidal radioiodine uptake. We tested this effect in vivo, using C57BL/6j
mice, and in vitro, using Fisher rat thyroid (FRTL-5) cells. One mouse received 2.5
mg theophylline i.p., whereas a control mouse received only saline. Twenty-hours
after theophylline, mice were injected with 10  Ci Na
125I in 0.1 mL saline through the
tail vein. Mean thyroidal 
125I activity was 3.3-fold higher in theophylline-treated mice
than in their respective controls. Radioiodine uptake and intracellular cAMP produc-
tion of FRTL-5 cells were increased by a relatively low concentration of theophylline
(1  M). Intracellular cAMP increased up to 30 min and then declined in response
to 1  M theophylline. Sera from theophylline-treated mice stimulated 
125I uptake and
intracellular cAMP production by FRTL-5 cells. These findings show that theophylline
can enhance radioiodine uptake by thyrocytes in vivo and in vitro. The in vitro effects
of theophylline on both radioiodine uptake and cAMP production in a dose-dependent
manner are consistent with an action mediated by phosphodiesterase inhibition.
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Radioiodine uptake by FRTL-5 cells
The in vitro uptake of Na125I by rat thyroid FRTL-5 cells
(Interthyr Research Foundation, Baltimore, MD, U.S.A.;
ATCC CRL 8305) was measured as described by Weiss et al.
(7) with slight modification. Briefly, cells were grown in 24-
well plates at 37℃ in 5% CO2, for 2-3 days in Coon’s mod-
ified F-12 medium containing 5% heat-treated, mycoplasma-
free calf serum (Life Technologies), 1 mM non-essential amino
acids (Life Technologies) supplemented with a mixture of six
hormones, including 10  g/mL insulin, 0.4 ng/mL cortisol,
5  g/mL transferrin, 2 ng/mL glycyl-L-histidyl-L-lysine ace-
tate, 10 ng/mL somatostatin and 10-10 M bovine TSH. These
hormones, except cortisol (Calbiochem, La Jolla, CA, U.S.A.),
were obtained from Sigma (St. Louis, MO, U.S.A.). Cells were
exposed for various times to different concentrations of theo-
phylline (Sigma), either added directly to culture medium
or to serum drawn from a mouse that had been injected with
theophylline. After aspirating the culture medium, cells were
washed with 1 mL of buffer of following composition: Hanks’
balanced salt solution (Life Technologies), which contains
calcium and magnesium but does not contain sodium bicar-
bonate, phenol red, or BSA, with 10 mM HEPES buffer (Life
Technologies), pH 7.3 (HBSS).  125I uptake was initiated by
adding 0.5 mL of warm buffered HBSS containing 10  M
NaI and Na125I (0.1  Ci/mL, to have around 100,000 cpm
per well). Incubations proceeded for 45 min at 37℃ water
bath, and were terminated by aspirating the radioactive medi-
um and washing with 1 mL of ice-cold HBSS twice. To deter-
mine the amount of Na125I associated with the cells, 1 mL of
ice-cold absolute ethanol was added to each well and incubated
for 3 hr at 4℃. The supernatants containing alcohol extracts
were transferred into vials for gamma counting. Radioiodine
uptake is expressed as cpm per optical density of DNA in each
well measured in an ELISA reader (Dynatech Laboratories,
Chantilly, VA, U.S.A.) after reacting the cells with dipheny-
lamine solution (Sigma) overnight (8).
Measurement of FRTL-5 cell intracellular and total cAMP
Intracellular and total cAMP levels of FRTL-5 cells were
measured using a commercial cAMP enzymatic immunoas-
say kit (Amersham Pharmacia Biotech Inc, Piscataway, NJ,
U.S.A.). Cells were plated in 96-well microtiter plates, at a
concentration of 1×106 cells/mL, and incubated overnight
at 37℃ in 5% CO2. After stimulating the cells with medi-
um containing different concentrations of theophylline or
serum, a lytic solution containing dodecyltrimethylammo-
nium bromide was either added after aspirating the culture
media for subsequent intracellular cAMP quantitation or
directly introduced into culture media for total cAMP mea-
surement. Lysis of the cells was performed for 10 min by shak-
ing the plate on a microtiter plate shaker. Standard solutions
and samples from each well pipetted into microtiter plates
coated with donkey anti-rabbit IgG. Optical density in each
plate was determined reader at 450 nm, following the pro-
cedure recommended by manufacturer.
Statistical analysis
Student’s t test and one-way ANOVA were used. Differ-
ences were considered statistically significant at p<0.05.
RESULTS
Radioiodine uptake study in normal mice
The kinetics of radioiodine uptake in normal mice thyroid
tissue and muscle after tail vein injection was first studied.
Peak thyroidal uptake was observed at 4 hr after injection (Fig.
1), which led us to measure radioiodine uptake at this time
point in future experiments. Within each pair of mice, net
thyroidal 125I activity was greater in all ten of the theophylline-
treated mice, 440,451±383,362 vs. 196,037±235,435
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Fig. 1. Kinetics of radioiodine uptake in normal mice. Two C57BL/6j
mice for each time point received 5  Ci Na
125I in 0.1 mL saline by
tail vein injection. 
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Fig. 2. In vivo thyroidal radioiodine uptake.706 J.M. Lee, P. Caturegli, P.W. Ladenson
cpm/mg (mean±SD, p<0.01 by Student’s paired t test), even
though there was considerable variation in the degree of uptake
among the pairs. Overall, thyroidal 125I activity was 3.3-fold
higher in theophylline-treated mice than in their respective
controls (range 1.5- to 6.7-fold increases) (Fig. 2). No mice
died before sacrifice or manifested behavior suggesting theo-
phylline toxicity.
Radioiodine uptake of FRTL-5 cells in response to theo-
phylline
When FRTL-5 cells were incubated with theophylline in
different concentrations for more than 30 min up to 20 hr, the
same exposure time employed for in vivo studies, intracellular
125I activity was not significantly different with any theophyl-
line concentration from that of cells incubated with medium
alone (data not shown). FRTL-5 cells were then exposed to
different concentrations of theophylline (1, 10, 100 and 200
M) for 30 min. Only 1  M theophylline significantly inc-
reased intracellular 125I activity compared to cells incubated
with medium only (43,598±3,011 vs. 31,804±3,963 cpm/
DNA [O.D], means of triplicate±SD, p=0.015) (Fig. 3). How-
ever, no effect was observed with theophylline concentrations
that were comparable to therapeutic serum concentrations for
bronchial asthma (100  M) and higher (200  M).
Intracellular and total cAMP response of FRTL-5 cells to
theophylline 
We investigated the time course of the intracellular cAMP
concentrations of FRTL-5 cells in responses to 1  M theo-
phylline. Intracellular cAMP increased up to 30 min and then
declined significantly (159±28 at basal, 688±104 at 30
min, 306±40 pmol/well at 120 min, means of triplicate±
SD, p=0.001) (Fig. 4A). FRTL-5 cells were then exposed to
various concentrations of theophylline for 30 min. Intracel-
lular cAMP concentration of the cells incubated with 1  M
theophylline was higher than that of cells incubated with
medium only (528 vs. 109 pmol/well, mean of duplicates).
Although no significant increase in intracellular cAMP was
observed at higher theophylline concentrations (10, 100 and
200  M), total cAMP (cellular+medium cAMP) was increased
in a dose-dependent manner throughout the studied theo-
phylline dose range (Fig. 4B). 
In vitro radioiodine uptake and cAMP responses to mouse
sera
FRTL-5 cells were incubated for 30 min with control mouse
serum or serum taken 20 h after the mouse had received theo-
phylline 2.5 mg i.p. Theophylline-treated mouse serum sig-
nificantly increased radioiodine uptake by FRTL-5 cells at
dilutions 1:200 and 1:100 compared to control mouse serum
(46,531±4,577 vs. 36,916±3,674 cpm/DNA [O.D] at 1:
200, 48,529±4,455 vs. 35,982±4,154 cpm/DNA [O.D]
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Fig. 3. Radioiodine activity in FRTL-5 cells in response to theophyl-
line.
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Fig. 4. cAMP concentration in FRTL-5 cells in response to theophylline. Cells were cultured in triplicate (A) or in duplicate (B) with cell con-
centration of 10
6 cells/mL in 96-well culture plates. (A) FRTL-5 cells were incubated with 1  M theophylline for various time periods. (B) Cells
were stimulated with various concentrations of theophylline for 30 min.
c
A
M
P
 
(
p
m
o
l
/
w
e
l
l
)
1,000
800
600
400
200
0
0 1 10 100 200
Concentration of theophylline ( M)
Total (intracellular+medium) cAMP
Intracellular cAMP
A BTheophylline Effects on Thyroidal Radioiodine Uptake 707
at 1:100, means of triplicate±SD, p<0.05) (Fig. 5A). Serum
from the theophylline-treated mouse also showed a greater
intracellular concentration of cAMP within FRTL-5 cells com-
pared to control mouse serum (303 vs. 191 pmol/well at 1:100
dilution, mean of duplicates) (Fig. 5B).
DISCUSSION
The transport of iodide, the first step in thyroid hormone
biosynthesis, is a specialized process performed most effici-
ently by thyrocytes. The ability of TSH to stimulate iodide
accumulation in the thyroid was first established in 1960 (9).
In rats, injection of TSH caused 50-100% increase in thyroid
iodide accumulation after 8 hr, as measured by the thyroid-to-
serum radioiodide gradient. The maximum increase was de-
tected 24-48 hr after injection. Similar experiments conduct-
ed in the 1970’s in isolated bovine thyroid cells also showed
50-100% stimulation of accumulation 6 hr after addition of
TSH in vitro (10, 11). This effect of TSH was reproduced by
dibutyryl cAMP and by agents that increased intracellular
levels of cAMP, such as the diterpene forskolin, further sug-
gesting that the effect of TSH on the iodide transport system
is mediated by cAMP (6, 7, 11, 12). In addition to iodide
uptake, it is generally accepted that TSH stimulation of other
steps in thyroid hormone biosynthesis, including thyroglob-
ulin biosynthesis and thyroid hormone release, requires an
increase in adenylate cyclase and intracellular cAMP content
(13, 14). 
Theophylline inhibits the activity of phosphodiesterase,
which catalyzes degradation of cAMP to AMP. Consequent-
ly, it can increase the intracellular cAMP level and augment
cAMP-mediated intracellular responses in thyrocytes (15-18).
Bastomsky and McKenzie (15, 16) found that theophylline
had a stimulatory effect on the thyroid and potentiated the
effects of TSH. Ahn and Rosenberg (6) observed prompt stim-
ulation of thyroid hormone production by cAMP and TSH
injected into rats, and similar effects of theophylline. Wolf
and Varrone (19) reported that simultaneous administration
of theophylline and propylthiouracil potentiated the goitro-
genic effect of the latter without increasing the plasma TSH
level. Kapitola et al. (20) found an increase in radioiodine up-
take by thyroid in rats and mice after 4 i.p. injections of 1 or
10 mg theophylline, even when endogenous secretion of TSH
was blocked by thyroxine. Gafni and Gross (21) reported a
large dose of TSH combined with theophylline doubled the
level of the thyroidal cAMP compared with TSH alone in
normal mice. 
We report in vivo and in vitro studies that more fully de-
fined the time- and dose-dependent effects of theophylline on
cAMP production and radioiodine uptake. We have investi-
gated effects of theophylline on both murine thyroidal radioio-
dine uptake and on intracellular accumulation of radioiodide
in cultured FRTL-5 cells in which simultaneous cAMP deter-
minations could be made. FRTL-5 cells are known to express
many characteristics of thyroid follicular cells in vivo, except
that they do not form the follicular architecture of intact thyroid
tissue. Specifically, FRTL-5 cells concentrate iodide approxi-
mately 30-fold, mimicking the iodide accumulation observed
in thyroid tissue slice and primary cell culture systems (7). 
Both the intracellular cAMP concentration and radioiodine
uptake of FRTL-5 cells increased 30 min after exposure to
either 1  M theophylline directly or in serum from a theo-
phylline-treated mouse. The rapid onset of this in vitro theo-
phylline effect contrasts to that of TSH (9-11) and may be
attributable to its more proximate action to increase the intra-
cellular cAMP concentration. This theophylline effect was
reversed when FRTL-5 cells were exposed to concentrations
of theophylline greater than 1  M or incubated for more than
30 min. A direct cytotoxic effect of theophylline or radioio-
dine on FRTL-5 cells seems unlikely since the cellular DNA
determined for each well was not significantly different after
incubation with theophylline or radioiodine for various time
and concentrations. Low theophylline concentrations may have
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Fig. 5. Radioiodine uptake and intracellular cAMP production by FRTL-5 cells in response to serum. FRTL-5 cells were cultured in triplicate
in 24-well culture plates to measure radioiodine uptake (A), and in duplicate in 96-well culture plates for cAMP measurement (B). 
A
*
*
*
*
serum of theophylline-treated mouse
serum of control mouse
c
A
M
P
 
(
p
m
o
l
/
w
e
l
l
)
400
350
300
250
200
150
100
50
Medium only 1:10,000 1:1000 1:200 1:100
Dilution of serum B
serum of theophylline-treated mouse
serum of control mousemaximally inhibited phosphodiesterase activity, and higher
levels may simply result in the egress of cAMP from cells into
the medium. Previous studies employing methylxanthines to
study TSH-mediated changes in cAMP have shown a similar
phenomenon: the initial rise in intracellular cAMP in thyro-
cytes subsequently declined after 30 min, principally due to
the release of nucleotide into media (22-25). 
In contrast to these in vitro results, radioiodine uptake by
the intact murine thyroid was higher even 20 hr after exposure
to theophylline. This finding suggests that intact thyroid cells
may be able to sustain augmented cAMP levels and not be-
come desensitized despite sustained phsophodiesterase inhi-
bition. It is also possible that the membrane of thyroid cells
in vivo may remain relatively impermeable to cAMP under
physiologic conditions. 
There are few reports of long-term effects of theophylline
on the thyroid function. Schreiber et al. (26) reported that stim-
ulatory effect of theophylline on the radioiodine uptake by rat
thyroid is only of transitory nature and does not persist more
than 4 weeks. In humans, short-term administration (less than
4 weeks) of theophylline increased serum free thyroxine and
free triiodothyronine concentrations, but there was no sustained
effect with long-term therapy (27). Other investigators have
reported that the short-term increase in serum thyroxine con-
centration induced by theophylline was correlated with the
rise in plasma cAMP (28). 
Our findings clearly support the hypothesis that theophyl-
line can enhance cAMP-mediated radioiodine uptake by thy-
rocytes in vivo and in vitro. The effects of theophylline in our
studies both cAMP production and radioiodine uptake were
time- and dose-dependent, consistent with an action medi-
ated by phosphodiesterase inhibition. Augmenting thyroidal
radioiodine uptake by theophylline could enhance radioiso-
topic approaches to diagnose and treat thyroid disorders. In
this regard, it is interesting that certain well-differentiated
thyroid cancers have been observed to have higher phospho-
diesterase activity (29). However, the efficiency of radioiodine
for treatment of thyroid cancer and hyperthyroidism, in par-
ticular, depends not only on the fractional thyroidal uptake
of radioiodine but also its residence time in the gland (3-5).
If theophylline accelerates the subsequent steps in thyroid
hormone production that lead to the egress of organified ra-
dioiodine from the gland, then the net cellular radiation dose
may not prove to be increased. Further in vivo studies will be
required to address this issue. 
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